Role of Platelet-Activating Factor in Two-Kidney, One-Clip Hypertension

International Journal of Urology

Volumn 4, Issue 4, 1997, Pages 388-393

  Takahashi, Shinichi ^a   Imagawa, Masaharu ^a   Mimata, Hiromitsu ^a   Nakagawa, Masayuki ^a   Ogata, Jiro ^a   Nomura, Yoshio ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Cholinephosphotransferase; Kidney; Platelet activating factor; Two kidney one clip hypertensive rats

Indexed keywords

2 [N (2 METHOXY 3 OCTADECYLCARBAMOYLOXYPROPOXYCARBONYL)ACETAMIDOMETHYL] 1 ETHYLPYRIDINIUM CHLORIDE; CHOLINEPHOSPHOTRANSFERASE; PYRIDINIUM DERIVATIVE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL; ARTICLE; BLOOD PRESSURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CIRCULATION; KIDNEY MEDULLA; MALE; METABOLISM; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; RENOVASCULAR HYPERTENSION; VASCULARIZATION; WISTAR RAT;

ANIMALS; BLOOD PRESSURE; DIACYLGLYCEROL CHOLINEPHOSPHOTRANSFERASE; HYPERTENSION, RENOVASCULAR; INJECTIONS, INTRAVENOUS; KIDNEY MEDULLA; MALE; ORGAN SIZE; PLATELET ACTIVATING FACTOR; PYRIDINIUM COMPOUNDS; RATS; RATS, WISTAR; RENAL CIRCULATION;

EID: 0031183499     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-2042.1997.tb00213.x     Document Type: Article

References (22)

1. Mizoguchi H, Nomura Y, Ogata S, Kawashima Y, Ogata J. Role of the kallikrein-kinin system in two-kidneyed and one-clipped hypertensive rats. Urol Int 1987;42:14-18.
2. Muirhead EE, Folkow B, Byers LW, Desiderio DM, Thoren P, Gothberg G, Dow AW, Brooks B. Cardiovascular effects of antihypertensive polar and neutral renomedullary lipids. Hypertension 1983;5(suppl. I): I-112-I-118.
3. Heptinstall RH, Salyer DC, Slyer WR. Experimental hypertension. The effects of chemical ablation of the renal papilla on the blood pressure of rats with and without silver-clip hypertension. Am J Pathol 1975; 78:297-308.
4. Bing RF, Russel GI, Swales JD, Thurston H, Fletcher A. Chemical renal medullectomy: effect upon reversal of two-kidney, one-clip hypertension in the rat. Clin Sci 1981;61:335s-338s.
5. Caramelo C, Fernandez-Gallardo S, Marin-Cao D, Inarrea P, Santos JC, Lopez-Novoa JM, Crespo MS. Presence of platelet-activating factor in blood from humans and experimental animals: its absence in anephric individuals. Biochem Biophys Res Commun 1984; 120:789-796.
6. Imagawa M, Mimata H, Takahashi S, Nakagawa M, Nomura Y, Ogata J. Modulation of platelet-activating factor synthesis by recombinant interferon-α in human renal cell carcinoma. Urol Int 1996;57:11-16.
7. Masugi F, Ogihara T, Saeki S, Otsuka A, Kumahara Y. Role of acetyl glyceryl ether phosphorylcholine in blood pressure regulation in rats. Hypertension 1985;7:742-746.
8. Leenen FHH, de Jong W. A solid silver clip for induction of predictable levels of renal hypertension in the rat. J Appl Physiol 1971;31:142-144.
9. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
10. Janero DR, Burghardt C. Solid-phase extraction on silica cartridges as an aid to platelet-activating factor enrichment and analysis. J Chromatogr 1990;526:11-24.
11. Renooij W, Snyder F. Biosynthesis of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet activating factor and a hypotensive lipid) by cholinephosphotransferase in various rat tissues. Biochim Biophys Acta 1981; 663:545-556.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. Woodard DS, Lee TC, Snyder F. The final step in the de novo biosynthesis of platelet activating factor. Properties of a unique CDP-choline: 1-alkyl-2-acetyl-sn-glycerol choline-phosphotransferase in microsomes from the renal inner medulla of rats. J Biol Chem 1987; 262:2520-2527.
14. Terashita Z, Imura Y, Takatani M, Tsushima S, Nishikawa K. CV-6209, a highly potent antagonist of platelet activating factor in vitro and in vivo. J Pharmacol Exp Ther 1987;242:263-268.
15. Snyder F. Chemical and biochemical aspects of platelet activating factor: a novel class of acetylated ether-linked choline-phospholipids. Med Res Rev 1985;5:107-140.
16. Handa RK, Strandhoy JW, Buckalew VM Jr. Platelet-activating factor is a renal vasodilator in the anesthetized rat. Am J Physiol 1990;258:F1504-F1509.
17. Brezis M, Rosen S. Hypoxia of the renal medulla - its implication for disease. N Engl J Med 1995;332:647-655.
18. Caplan MS, Adler L, Kelly A, Hsueh W. Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells. Biochim Biophys Acta 1992;1128:205-210.
19. Branquet P, Spinnewyn B, Blavet N, Marcheselli V, Rossawska M, Bazan NG. Platelet activating factor as a mediator in cerebral ischemia and related disorders. Biomed Biochim Acta 1988;47:195-218.
20. Lopez-Farre A, Torralbo M, Lopez-Novoa JM. Glomeruli from ischemic rat kidney produce increased amount of platelet activating factor. Biochem Biophys Res Commun 1988;152:129-135.
21. Filep J, Herman F, Branquet P, Mozes T. Increased level of platelet activating factor in blood following intestinal ischemia in the dog. Biochem Biophys Res Commun 1988;158:353-359.
22. Fukuoka T, Nakajima Y, Nakano H. Platelet-activating factor as a vasodepressive mediator of liver ischemia. Transplant Proc 1993;25:3225-3227.